Edwards Lifesciences (NYSE:EW) has announced that its Acumen hypotension prediction index (HPI) software has received FDA 510(k) clearance. Using data obtained from the Acumen IQ finger cuff, the software uses machine learning to alert clinicians of the likelihood a patient is trending toward hypotension, or low blood pressure. Until now, Acumen HPI software has only […]
Edwards Lifesciences
Barclays is bullish on medtech
A Barclays analysis projects that medtech might be on its way to a stretch of “outperformance” even in the wake of the COVID-19 pandemic. According to SeekingAlpha, the report cited eight reasons that make the investment bank bullish on the industry in the coming years, starting with what it calls “robust innovation.” On top of […]
Outset Medical appoints Edwards Lifesciences exec Katie Szyman to board of directors
Outset Medical (NSDQ:OM) announced that it appointed Edwards Lifesciences executive Katie Szyman to its board of directors. Szyman currently serves as corporate VP & GM of critical care at Edwards, having spent more than 30 years in leadership roles in the medtech space, according to a news release. Much of her experience came in 23 […]
5 of the latest cardiac tech insights out of ACC.21
The American College of Cardiology’s 70th Annual Scientific Session has produced some positive news about some controversial cardiac tech. Drug-coated stents, which a 2018 study linked to late-stage death, were shown to be non-inferior to non-drug-coated stents in patients with peripheral arterial disease. And a new study of renal denervation that used a different methodology […]
Edwards Lifesciences tricuspid valve reduced leakage in 98% of patients
Edwards Lifesciences‘s Evoque tricuspid valve replacement system reduces tricuspid heart valve leakage to non-traceable or mild leakage in 98% of patients, according to a new study reported at the American College of Cardiology’s 70th Annual Scientific Session. Evoque is designed to replace native tricuspid valves without open-heart surgery. The valve is implanted using a minimally […]
MedTech 100 roundup: New heights reached again
One week after recording its all-time best performance, the medtech industry again topped itself, storming even further ahead. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — has been on the rise since April began, with last week’s mark of 112.25 (April 16) representing an all-time best, topping the […]
Edwards rises after hours on Street-beating Q1
Edwards Lifesciences (NYSE:EW) shares ticked up after hours today on first-quarter results that topped the consensus forecast. The Irvine, Calif.–based company posted profits of $338.2 million, or 54¢ per share, on sales of $1.22 billion for the three months ended March 31, 2021, for an 8.9% bottom-line gain on sales growth of 7.8%. Adjusted to […]
4 innovative devices delivered through catheters
Physicians use catheters to deploy numerous life-saving devices across the healthcare realm, from cardiovascular to neurovascular. They typically insert the thin, flexible tubes in a process called catheterization to deploy devices such as left ventricular assist devices (LVADs), transcatheter aortic valve replacements (TAVRs) and occluders to stop bleeding. The catheter industry is regularly innovating to […]
8 medical device companies that beat the COVID-19 pandemic and prospered
Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]
How big medtech fared during a year of COVID-19
Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]
Edwards touts 5-year aortic valve trial results
Edwards Lifesciences (NYSE:EW) announced data showing favorable safety and hemodynamic performance from its Resilia tissue platform. Data from Edwards’ Commence clinical trial demonstrated that its bioprosthetic surgical aortic valve with the novel Resilia tissue aortic valve platform produced favorable results across a median of five years follow-up, according to a news release. Commence is a prospective, […]
